Searched for
PHARMACOVIGILANCE SYSTEM
Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...- Drug regulator cracks down on delayed safety reporting by pharma companiesIndia's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...
- Drugmakers flag concerns over blue-strip antibiotic labelsThe government mandated a blue line on antibiotic packaging to curb misuse. However, pharmaceutical companies argue this will disrupt opera...
- Thyroid, antibiotic drugs face fresh safety warnings after national reviewNew safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential ment...
- AI and Automation Are Reshaping Drug SafetyWith the increase in volume and complexity of drug safety data, artificial intelligence is transforming the functioning of pharmacovigilanc...
- Abhayrab rabies vaccine: IIL says counterfeit batch no longer availableIndian Immunologicals Limited clarifies a packaging anomaly in one batch of its anti-rabies vaccine, Abhayrab. The company states that coun...
- CDSCO directs pharmacies to display QR code and toll-free number for reporting adverse drug reactionsThe CDSCO has mandated that all retail and wholesale pharmacies across India must prominently display a QR code and a toll-free number. Thi...
- Graph AI raises $3 million seed funding for drug safety platformAI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup l...
- Wipro, Tech Mahindra, L&T Tech Services partner with NvidiaTech Mahindra has unveiled an autonomous pharmacovigilance (PV) solution powered by Nvidia AI software to enhance drug safety management.
- Govt issues guidance paper to strengthen vaccine companies' reporting of adverse eventsThe new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthe...
- Drug firms told to set up system for 'prompt' recallsIndia enforced 'Schedule M' for drug manufacturers, emphasizing quality, recall systems. Companies must comply with strict rules on hygiene...
- Meftal maker says adverse reaction flagged by IPC is very rareBlue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commiss...
- IPC to become first WHO Collaborating Centre in SE AsiaHealth Secretary BP Sharma said the importance of Pharmacovigilance has increased as there have been changes in the ways people take medici...
- Vigilance important to monitor adverse effects of drugs: JP NaddaHealth Minister JP Nadda today underlined the importance of pharmacovigilance, the monitoring of adverse effects of drugs in the country.
- Health ministry okays plan to monitor medical devices; vigilance cells to be set up nationwideTo begin with, MvPI cells are to be established in 10 medical colleges. These will be funded by the government to report online.
- Pharma companies may have to report drugs’ side effects to regulatorIndia is set to make it mandatory for pharmaceutical firms to report side effects of drugs to the regulator.
- Ban proposed on drugs having serious side effects"There are variations in each individual in conversions of codeine to morphine and each individual reacts differently," Prof K C Singhal.
- Indian pharmaceutical industry to reach $20 bn by 2015: AssochamAssocham has said it expects the Indian pharmaceutical industry to reach $20 billion by 2015, making it one of the world's top 10 pharmaceu...
- Centre may tighten quality check on drugsThe government may make it compulsory for all hospitals and medical institutions to report adverse drug reactions, a move, which could enab...
- Syngene signs agreement with Bristol-MyersBiocon’s subsidiary company Syngene said it has entered into a research partnership with Bristol-Myers Squibb.
Load More
